Navigation Links
Discovery Labs Reports Second Quarter 2013 Financial Results
Date:8/8/2013

WARRINGTON, Pa., Aug. 8, 2013 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today reported financial results for the second quarter ended June 30, 2013 and also provided a business update. The Company will host a conference call this morning at 10:00 AM ET.  Conference call details are below.

Key updates include:

  • SURFAXIN®:  On June 7, 2013, the Company submitted a response to a request by the U.S. Food and Drug Administration (FDA) for more information related to the Company's recently updated product specifications for SURFAXIN.  The Company expects that the FDA may take up to four months from the date of its submission to review the information provided.  If the FDA agrees with the response, the Company expects to proceed with the commercial introduction of SURFAXIN in the fourth quarter of 2013.  SURFAXIN is the first synthetic, peptide-containing surfactant approved by the FDA for use in neonatal medicine and is the only approved alternative to animal-derived surfactants in the U.S., which are currently the standard of care for respiratory distress syndrome (RDS).
  • AEROSURF®:  AEROSURF is a novel combination drug-device product being developed to deliver the Company's synthetic, peptide-containing surfactant in aerosolized form using its proprietary aerosolization technologies.  AEROSURF could potentially allow for the administration of the Company's surfactant to premature infants without having to use invasive endotracheal intubation and may enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy and currently are not treated.  The Company's AEROSURF development plan remains
    '/>"/>

  • SOURCE Discovery Laboratories, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Anti-Infective Services for Drug Discovery and Development, New Life Science Webinar Hosted by Xtalks
    2. Meso Scale Discovery Launches New Quickplex™ SQ 120 Multiplex Immunoassay Instrument
    3. Averica Discovery Announces Winner of First Averica Award for Supercritical Fluid Chromatography (SFC)
    4. Latest Cell Publication of OriGene and Peking University Collaborative Discovery of New iPSC Reprogramming Factors
    5. Health Diagnostic Laboratory, Inc.s new Diabetes Prevention & Management Panel incorporates discovery from Metabolon researchers
    6. New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products
    7. Discovery Labs Announces Completion of $14.25 Million Public Offering
    8. Discovery of gene mutation causing Sturge-Weber syndrome, port-wine stain birthmarks offers new hope
    9. Discovery Labs Prices $14.25 Million Public Offering of Common Stock
    10. Adaptive Biotechnologies Signs Biomarker Discovery Collaboration Agreement with Bristol-Myers Squibb
    11. Predictive Biomarker Discovery for Oncology Small-Molecules and Biologics - a Webinar Hosted by Xtalks
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... (PRWEB) October 21, 2014 Shimadzu Scientific ... LC/MS/MS data tool for the pain management and clinical ... data processing and review by allowing users to highlight ... clinicians. , QuantAnalytics allows analysts to filter results ... expedites data processing by eliminating the need to sift ...
    (Date:10/22/2014)... SC (PRWEB) October 22, 2014 ... of its cardiovascular pharmacogenetics menu, which enables healthcare ... outcomes. With PCLS’s evidence-based results, healthcare providers ... and optimize their therapy, while minimizing risks for ... the U.S., according to the FDA [1] more ...
    (Date:10/22/2014)... 22, 2014 Research and Markets  has ... by Material, by Application, Geography - Global Analysis and ... Organic electronics, also called as polymer ... science which deals with small conductive molecules and electrically ... molecules and polymers are carbon based, made using synthetic ...
    (Date:10/20/2014)... 2014 Asterias Biotherapeutics, Inc. (NYSE MKT: ... a Notice of Grant Award (NGA) with the ... 1, 2014.  The NGA provides for the immediate ... of additional grant funds pursuant to the previously ... development of Asterias, product, AST-OPC1. The grant provides ...
    Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
    ... Md., Oct. 4, 2011 Northwest Biotherapeutics (OTC.BB: ... be presenting at the second annual Cancer Immunotherapy: ... at the New York Academy of Medicine in ... opinion leaders, industry executives, and other stakeholders to ...
    ... LAFAYETTE, Ind., Oct. 4, 2011 Kylin Therapeutics, ... that it has received a notice of allowance ... for its second U.S. patent application. This newly ... as well as expanded areas on Kylin,s proprietary ...
    ... Oct. 4, 2011 Sequenom, Inc. (NASDAQ: ... analysis solutions, today announced the launch of its iPLEX ... associated with drug absorption, distribution, metabolism, and excretion (ADME). ... of pre-designed single nucleotide polymorphisms (SNP), insertions and deletions ...
    Cached Biology Technology:NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011 2NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011 3NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011 4Kylin Therapeutics Receives Notice of Allowance for Second U.S. Patent Covering Delivery of Therapeutic RNA and pRNAi Technology 2Sequenom Introduces iPLEX® ADME PGx Panel on MassARRAY® System 2Sequenom Introduces iPLEX® ADME PGx Panel on MassARRAY® System 3
    (Date:10/16/2014)... Post-menopausal women experienced improvements in vaginal atrophy, with ... bleeding, after 12 weeks of daily 10 milligram ... nutritional supplement previously shown to help relieve certain ... study reported in a poster at the North ... , "These data documented improved vaginal epithelium, without ...
    (Date:10/15/2014)... WASHINGTON, N.Y. , Oct. 15, 2014 /PRNewswire/ ... technology solutions for home and community-based care, today ... benefits of implementing Sandata,s Santrax® Electronic Visit Verification™ ... Care Services is a home health company founded ... Texas . The ...
    (Date:10/15/2014)... of Life, is a non-traditional biophysics textbook and it ... is a journey of discovery into biological systems and ... biological regulation. It is about how our genes make ... the billions of cells in an organism. It quantifies ... principles, which can be found on both large and ...
    Breaking Biology News(10 mins):S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2Sandata Announces Case Study with Quality Care Services, Inc. 2New book about life as seen from physics 2
    ... Troy, N.Y. Engineering researchers at Rensselaer Polytechnic Institute ... diverse areas to help create a closed-loop artificial pancreas. ... administer insulin to patients with Type 1 diabetes, and ... living with the chronic disease. For six years, ...
    ... A study conducted by VTT Technical Research Centre of Finland ... grades 95E10 and 98E5 sold in Finland as regards fuel ... tests conducted by VTT using six used cars of different ... claimed in public that fuel consumption is significantly higher with ...
    ... a low-cost healthy lifestyle program, including self-weighing weekly or ... them from gaining too much weight during early pregnancy. ... Endocrine Society,s 93rd Annual Meeting in Boston. "Preventing ... health of all mothers and their babies and can ...
    Cached Biology News:Engineering new weapons in the fight against juvenile diabetes 2Engineering new weapons in the fight against juvenile diabetes 3VTT: No significant difference in car fuel consumption between E10 and E5 petrol grades 2Pregnant women can prevent excess weight gain with simple steps, study finds 2
    ... Basic Package Superior Protein Detection and ... ProXPRESS 2D Proteomic Imaging System is a ... proteomic and general life science research applications. ... use of all dyes in the UV ...
    ... for the first time, you can identify ... more efficiently without interferences. The Agilent Multiple ... unwanted, multiple high-abundant proteins from human serum, ... just one device. With this revolutionary system, ...
    ... Arrays are intended for laboratory research use ... in neutral buffered formalin and embedded in ... performed by certified pathologists. Tissue cores ... relocated into a new recipient paraffin block, ...
    ... requiring confocal, the BD Pathway 415 is ... 435. And, the Pathway 415 can be ... it. High-performance, laser-based autofocus ... the laser autofocus, camera autofocus, or a ...
    Biology Products: